Kodiak Sciences (KOD) News Today $2.35 -0.05 (-2.08%) Closing price 04:00 PM EasternExtended Trading$2.35 0.00 (-0.21%) As of 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period HC Wainwright Weighs in on Kodiak Sciences Q1 EarningsApril 4 at 1:51 AM | americanbankingnews.comBrokers Set Expectations for Kodiak Sciences Q1 EarningsKodiak Sciences Inc. (NASDAQ:KOD - Free Report) - Analysts at HC Wainwright issued their Q1 2025 EPS estimates for shares of Kodiak Sciences in a research report issued on Monday, March 31st. HC Wainwright analyst M. Caufield forecasts that the company will post earnings per share of ($0.90) forApril 3 at 5:56 AM | marketbeat.comHC Wainwright Reaffirms "Neutral" Rating for Kodiak Sciences (NASDAQ:KOD)April 2 at 2:11 AM | americanbankingnews.comHC Wainwright Reiterates Neutral Rating for Kodiak Sciences (NASDAQ:KOD)HC Wainwright reaffirmed a "neutral" rating and set a $3.00 target price on shares of Kodiak Sciences in a report on Monday.April 1 at 8:19 AM | marketbeat.comKODIAK SCIENCES Earnings Results: $KOD Reports Quarterly EarningsMarch 29, 2025 | nasdaq.comKodiak Sciences (NASDAQ:KOD) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPSKodiak Sciences (NASDAQ:KOD - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.84) earnings per share for the quarter, beating analysts' consensus estimates of ($0.87) by $0.03.March 28, 2025 | marketbeat.comKodiak Sciences Inc.: Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial ResultsMarch 28, 2025 | finanznachrichten.deKodiak Sciences reports Q4 EPS 84c, consensus (86c)March 28, 2025 | markets.businessinsider.comKodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial ResultsMarch 27, 2025 | prnewswire.comIs Kodiak Sciences Inc. (KOD) The Hot Biotech Stock Under $5?March 26, 2025 | insidermonkey.comKodiak Appoints Peter Holbek as AdvisorMarch 26, 2025 | finance.yahoo.comKodiak Sciences (NASDAQ:KOD) and Metagenomi (NASDAQ:MGX) Head-To-Head SurveyMarch 26, 2025 | americanbankingnews.comKodiak Sciences (KOD) Expected to Announce Earnings on ThursdayMarch 25, 2025 | americanbankingnews.comBruce & Co. Inc. Lowers Holdings in Kodiak Sciences Inc. (NASDAQ:KOD)Bruce & Co. Inc. lowered its holdings in shares of Kodiak Sciences Inc. (NASDAQ:KOD - Free Report) by 23.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 323,000 shares of the company's stock after selMarch 22, 2025 | marketbeat.comKodiak Sciences (KOD) Expected to Announce Quarterly Earnings on ThursdayKodiak Sciences (NASDAQ:KOD) will be releasing earnings before the market opens on Thursday, March 27, Financial Modeling Prep reports.March 20, 2025 | marketbeat.comKOD Completes Enrollment in Phase III Study for Eye Disease CandidateMarch 12, 2025 | msn.comKodiak Sciences completes enrollment in GLOW2 Phase 3 trialMarch 10, 2025 | markets.businessinsider.comKodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic RetinopathyMarch 10, 2025 | prnewswire.comKodiak Sciences granted orphan designation for tabirafusp alfaMarch 4, 2025 | markets.businessinsider.comKodiak Sciences: Anti-VEGF Could Win Nicely On Retinal DisordersFebruary 23, 2025 | seekingalpha.comShort Interest in Kodiak Sciences Inc. (NASDAQ:KOD) Rises By 19.3%Kodiak Sciences Inc. (NASDAQ:KOD - Get Free Report) saw a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 2,040,000 shares, a growth of 19.3% from the January 15th total of 1,710,000 shares. Based on an average trading volume of 456,800 shares, the days-to-cover ratio is currently 4.5 days. Currently, 4.2% of the shares of the company are sold short.February 16, 2025 | marketbeat.comPeapod Lane Capital LLC Takes Position in Kodiak Sciences Inc. (NASDAQ:KOD)Peapod Lane Capital LLC acquired a new stake in Kodiak Sciences Inc. (NASDAQ:KOD - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 166,843 shares of the company's stock, valued at approximately $1February 13, 2025 | marketbeat.comKodiak Sciences to Present at Glaucoma 360 New Horizons Forum 2025February 4, 2025 | prnewswire.comKodiak Sciences Inc. (NASDAQ:KOD) Sees Large Increase in Short InterestKodiak Sciences Inc. (NASDAQ:KOD - Get Free Report) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 1,460,000 shares, a growth of 8.1% from the December 31st total of 1,350,000 shares. Based on an average daily trading volume, of 419,000 shares, the days-to-cover ratio is presently 3.5 days. Currently, 3.0% of the shares of the company are short sold.February 4, 2025 | marketbeat.comKodiak Sciences Inc. (NASDAQ:KOD) Short Interest Up 8.1% in DecemberKodiak Sciences Inc. (NASDAQ:KOD - Get Free Report) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totalling 1,460,000 shares, an increase of 8.1% from the December 15th total of 1,350,000 shares. Based on an average daily volume of 419,000 shares, the days-to-cover ratio is currently 3.5 days. Approximately 3.0% of the company's stock are sold short.January 19, 2025 | marketbeat.comKodiak Sciences to Present at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7, 2025 | prnewswire.comKodiak Sciences (NASDAQ:KOD) Trading Down 2.9% - Time to Sell?Kodiak Sciences (NASDAQ:KOD) Shares Down 2.9% - Time to Sell?January 2, 2025 | marketbeat.comInstitutional investors have a lot riding on Kodiak Sciences Inc. (NASDAQ:KOD) with 43% ownershipDecember 28, 2024 | finance.yahoo.comKodiak Sciences (NASDAQ:KOD) Shares Down 7.5% - Time to Sell?Kodiak Sciences (NASDAQ:KOD) Shares Down 7.5% - Should You Sell?December 27, 2024 | marketbeat.comKodiak Sciences (NASDAQ:KOD) Stock Price Up 6.7% - What's Next?Kodiak Sciences (NASDAQ:KOD) Trading Up 6.7% - What's Next?December 24, 2024 | marketbeat.comKodiak Sciences (NASDAQ:KOD) Shares Gap Up - Here's WhyKodiak Sciences (NASDAQ:KOD) Shares Gap Up - Should You Buy?December 23, 2024 | marketbeat.comNona Biosciences and Kodiak Sciences Partner on Next-Generation Antibody Therapies for Ophthalmic DiseasesDecember 10, 2024 | finance.yahoo.comJefferies Upgrades Kodiak Sciences (KOD)December 9, 2024 | msn.comKodiak stock rallies 32% after Jefferies upgrades to buyDecember 9, 2024 | msn.comEye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades StockDecember 9, 2024 | benzinga.comKodiak Sciences (NASDAQ:KOD) Stock Rating Upgraded by Jefferies Financial GroupJefferies Financial Group upgraded shares of Kodiak Sciences from a "hold" rating to a "buy" rating and set a $20.00 price objective for the company in a research report on Monday.December 9, 2024 | marketbeat.comKodiak Sciences Inc. (NASDAQ:KOD) Shares Sold by Jacobs Levy Equity Management Inc.Jacobs Levy Equity Management Inc. lowered its position in Kodiak Sciences Inc. (NASDAQ:KOD - Free Report) by 16.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 580,783 shares of thDecember 9, 2024 | marketbeat.comKodiak Sciences' SWOT analysis: biotech firm's stock faces pivotal trialsNovember 23, 2024 | uk.investing.com287,756 Shares in Kodiak Sciences Inc. (NASDAQ:KOD) Acquired by GSA Capital Partners LLPGSA Capital Partners LLP acquired a new position in Kodiak Sciences Inc. (NASDAQ:KOD - Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 287,756 shares of the company's stock, valNovember 18, 2024 | marketbeat.comKodiak Sciences Inc.: Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial ResultsNovember 17, 2024 | finanznachrichten.deKodiak: Tarcocimab Faces High Barriers To Entry Despite Resurrection (Rating Upgrade)November 15, 2024 | seekingalpha.comKodiak Sciences price target raised to $4 from $3 at BarclaysNovember 15, 2024 | markets.businessinsider.comKodiak Sciences Reports Q3 2024 Financial ResultsNovember 15, 2024 | markets.businessinsider.comBarclays Issues Positive Forecast for Kodiak Sciences (NASDAQ:KOD) Stock PriceBarclays boosted their target price on Kodiak Sciences from $3.00 to $4.00 and gave the company an "underweight" rating in a research note on Friday.November 15, 2024 | marketbeat.comKodiak Sciences (NASDAQ:KOD) Earns "Neutral" Rating from HC WainwrightHC Wainwright reissued a "neutral" rating and issued a $3.00 target price on shares of Kodiak Sciences in a research note on Friday.November 15, 2024 | marketbeat.comKodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial ResultsNovember 14, 2024 | prnewswire.comKodiak Sciences to Participate in Upcoming Investor ConferencesNovember 11, 2024 | prnewswire.comKodiak Sciences Share Price (KOD.US)November 1, 2024 | lse.co.ukAnalysts Issue Forecasts for Kodiak Sciences Q3 EarningsKodiak Sciences Inc. (NASDAQ:KOD - Free Report) - Equities researchers at Zacks Research increased their Q3 2025 earnings estimates for shares of Kodiak Sciences in a research report issued on Tuesday, October 22nd. Zacks Research analyst R. Department now forecasts that the company will post earOctober 25, 2024 | marketbeat.comKodiak Sciences Inc. (NASDAQ:KOD) Sees Large Decline in Short InterestKodiak Sciences Inc. (NASDAQ:KOD - Get Free Report) was the recipient of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 1,540,000 shares, a drop of 10.5% from the September 15th total of 1,720,000 shares. Approximately 3.2% of the company's shares are short sold. Based on an average daily volume of 200,200 shares, the days-to-cover ratio is currently 7.7 days.October 16, 2024 | marketbeat.com Remove Ads Get Kodiak Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KOD and its competitors with MarketBeat's FREE daily newsletter. Email Address KOD Media Mentions By Week KOD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KOD News Sentiment▼0.660.61▲Average Medical News Sentiment KOD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KOD Articles This Week▼122▲KOD Articles Average Week Remove Ads Get Kodiak Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KOD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BCYC News Today IMNM News Today DNTH News Today PHAR News Today GHRS News Today KALV News Today QURE News Today ANAB News Today MRVI News Today ORGO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KOD) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kodiak Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kodiak Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.